{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:00:19Z","timestamp":1772640019782,"version":"3.50.1"},"reference-count":21,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Malignant pleural mesothelioma is a pathology with no effective therapy and\na poor prognosis. Our previous study demonstrated an in vitro inhibitory effect on mesothelioma cell\nlines of both the lysate and secretome of adipose tissue-derived Mesenchymal Stromal Cells. The inhibitory\nactivity on tumor growth has been demonstrated also in vivo: five million Mesenchymal Stromal\nCells, injected \u201cin situ\u201d, produced a significant therapeutic efficacy against MSTO-211H xenograft\nequivalent to that observed after the systemic administration of paclitaxel.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of this study is to evaluate the efficacy of low amount (half a million) Mesenchymal\nStromal Cells and micro-fragmented adipose tissues (the biological tissue from which the Mesenchymal\nStromal Cells were isolated) on mesothelioma cells growth.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Tumor cells growth inhibition was evaluated in vitro and in a xenograft model of mesothelioma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The inhibitory effect of micro-fragmented fat from adipose-tissue has been firstly confirmed\nin vitro on MSTO-211H cell growth. Then the efficacy against the growth of mesothelioma xenografts\nin mice of both micro-fragmented fat and low amount of Mesenchymal Stromal Cells has been evaluated.\nOur results confirmed that both Mesenchymal Stromal Cells and micro-fragmented fat, injected\n\u201cin situ\u201d, did not stimulate mesothelioma cell growth. By contrast, micro-fragmented fat produced a\nsignificant inhibition of tumor growth and progression, comparable to that observed by the treatment\nwith paclitaxel. Low amount of Mesenchymal Stromal Cells exerted only a little anticancer activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Micro-fragmented fat inhibited mesothelioma cell proliferation in vitro and exerted a significant\ncontrol of the mesothelioma xenograft growth in vivo.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568009623666230201092302","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T12:50:29Z","timestamp":1675255829000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma\nXenografts in Mice"],"prefix":"10.2174","volume":"23","author":[{"given":"Silvia","family":"La Monica","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Cocc\u00e9","sequence":"additional","affiliation":[{"name":"CRC StaMeTec,\nDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122,\nItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Bonelli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Alessandri","sequence":"additional","affiliation":[{"name":"CRC StaMeTec,\nDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122,\nItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Alfieri","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costanza Annamaria","family":"Lagrasta","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Frati","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Flammini","sequence":"additional","affiliation":[{"name":"Food and Drug Department, University of Parma, Parco Area delle Scienze 27\/A, Parma, 43124, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Gianni","sequence":"additional","affiliation":[{"name":"CRC StaMeTec,\nDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122,\nItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Petrella","sequence":"additional","affiliation":[{"name":"CRC StaMeTec,\nDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122,\nItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Paino","sequence":"additional","affiliation":[{"name":"CRC StaMeTec,\nDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122,\nItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Pessina","sequence":"additional","affiliation":[{"name":"CRC StaMeTec,\nDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122,\nItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"Carbone M.","year":"2012","unstructured":"Carbone M.; Ly B.H.; Dodson R.F.; Pagano I.; Morris P.T.; Dogan U.A.; Gazdar A.F.; Pass H.I.; Yang H.; Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012,227(1),44-58","journal-title":"J Cell Physiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","volume":"13","author":"Mutti L.","year":"2018","unstructured":"Mutti L.; Peikert T.; Robinson B.W.S.; Scherpereel A.; Tsao A.S.; de Perrot M.; Woodard G.A.; Jablons D.M.; Wiens J.; Hirsch F.R.; Yang H.; Carbone M.; Thomas A.; Hassan R.; Scientific advances and new frontiers in mesothelioma therapeutics. J Thorac Oncol 2018,13(9),1269-1283","journal-title":"J Thorac Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3892\/ol.2015.3997","volume":"11","author":"Li G.C.","year":"2016","unstructured":"Li G.C.; Zhang H.W.; Zhao Q.C.; Sun L.; Yang J.J.; Hong L.; Feng F.; Cai L.; Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor \u03b21. Oncol Lett 2016,11(2),1089-1094","journal-title":"Oncol Lett"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","volume":"280","author":"Ayuzawa R.","year":"2009","unstructured":"Ayuzawa R.; Doi C.; Rachakatla R.S.; Pyle M.M.; Maurya D.K.; Troyer D.; Tamura M.; Na\u00efve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett 2009,280(1),31-37","journal-title":"Cancer Lett"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13287-016-0282-7","volume":"7","author":"Cortes-Dericks L.","year":"2016","unstructured":"Cortes-Dericks L.; Froment L.; Kocher G.; Schmid R.A.; Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines. Stem Cell Res Ther 2016,7(1),25","journal-title":"Stem Cell Res Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/cells10061427","volume":"10","author":"Cocc\u00e8 V.","year":"2021","unstructured":"Cocc\u00e8 V.; La Monica S.; Bonelli M.; Alessandri G.; Alfieri R.; Lagrasta C.A.; Madeddu D.; Frati C.; Flammini L.; Lisini D.; Marcianti A.; Parati E.; Paino F.; Giann\u00ec A.; Farronato G.; Falco A.; Spaggiari L.; Petrella F.; Pessina A.; Inhibition of human malignant pleural mesothelioma growth by mesenchymal stromal Cells. Cells 2021,10(6),1427","journal-title":"Cells"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1432-0436.1988.tb00806.x","volume":"37","author":"Bepler G.","year":"1988","unstructured":"Bepler G.; Koehler A.; Kiefer P.; Havemann K.; Beisenherz K.; Jaques G.; Gropp C.; Haeder M.; Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines. Differentiation 1988,37(2),158-171","journal-title":"Differentiation"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2019.03.016","volume":"302","author":"Alessandri G.","year":"2019","unstructured":"Alessandri G.; Cocc\u00e8 V.; Pastorino F.; Paroni R.; Dei Cas M.; Restelli F.; Pollo B.; Gatti L.; Tremolada C.; Berenzi A.; Parati E.; Brini A.T.; Bondiolotti G.; Ponzoni M.; Pessina A.; Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy. J Control Release 2019,302,2-18","journal-title":"J Control Release"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13221-016-0037-3","volume":"8","author":"Ceserani V.","year":"2016","unstructured":"Ceserani V.; Ferri A.; Berenzi A.; Benetti A.; Ciusani E.; Pascucci L.; Bazzucchi C.; Cocc\u00e8 V.; Bonomi A.; Pessina A.; Ghezzi E.; Zeira O.; Ceccarelli P.; Versari S.; Tremolada C.; Alessandri G.; Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells. Vasc Cell 2016,8(1),3","journal-title":"Vasc Cell"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13046-017-0653-7","volume":"36","author":"La Monica S.","year":"2017","unstructured":"La Monica S.; Cretella D.; Bonelli M.; Fumarola C.; Cavazzoni A.; Digiacomo G.; Flammini L.; Barocelli E.; Minari R.; Naldi N.; Petronini P.G.; Tiseo M.; Alfieri R.; Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines. J Exp Clin Cancer Res 2017,36(1),174","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13046-019-1240-x","volume":"38","author":"La Monica S.","year":"2019","unstructured":"La Monica S.; Minari R.; Cretella D.; Flammini L.; Fumarola C.; Bonelli M.; Cavazzoni A.; Digiacomo G.; Galetti M.; Madeddu D.; Falco A.; Lagrasta C.A.; Squadrilli A.; Barocelli E.; Romanel A.; Quaini F.; Petronini P.G.; Tiseo M.; Alfieri R.; Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC. J Exp Clin Cancer Res 2019,38(1),222","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/molecules27030991","volume":"27","author":"Antunes P.","year":"2022","unstructured":"Antunes P.; Cruz A.; Barbosa J.; Bonif\u00e1cio V.D.B.; Pinto S.N.; Lipid droplets in cancer: From composition and role to imaging and therapeutics. Molecules 2022,27(3),991","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-020-2297-3","volume":"11","author":"Cruz A.L.S.","year":"2020","unstructured":"Cruz A.L.S.; Barreto E.A.; Fazolini N.P.B.; Viola J.P.B.; Bozza P.T.; Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis 2020,11(2),105","journal-title":"Cell Death Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41598-020-80484-x","volume":"11","author":"Abedin M.R.","year":"2021","unstructured":"Abedin M.R.; Barua S.; Isolation and purification of glycoglycerolipids to induce apoptosis in breast cancer cells. Sci Rep 2021,11(1),1298","journal-title":"Sci Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2015.10.113","volume":"468","author":"Zhai L.","year":"2015","unstructured":"Zhai L.; Sun N.; Han Z.; Jin H.; Zhang B.; Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo. Biochem Biophys Res Commun 2015,468(1-2),274-280","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40005-020-00475-y","volume":"50","author":"Choi M.K.","year":"2020","unstructured":"Choi M.K.; Song I.S.; Recent advances in the formulation of sphingolipid anticancer therapeutics. J Pharm Investig 2020,50(3),295-307","journal-title":"J Pharm Investig"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-14-1","volume":"14","author":"Lin I.L.","year":"2014","unstructured":"Lin I.L.; Chou H.L.; Lee J.C.; Chen F.W.; Fong Y.; Chang W.C.; Huang H.W.; Wu C.Y.; Chang W.T.; Wang H.M.D.; Chiu C.C.; The antiproliferative effect of C2-ceramide on lung cancer cells through apoptosis by inhibiting Akt and NF\u03baB. Cancer Cell Int 2014,14(1),1","journal-title":"Cancer Cell Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"565316","DOI":"10.1155\/2011\/565316","volume":"2011","author":"Huang W.C.","year":"2011","unstructured":"Huang W.C.; Chen C.L.; Lin Y.S.; Lin C.F.; Apoptotic sphingolipid ceramide in cancer therapy. J Lipids 2011,2011,565316","journal-title":"J Lipids"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"172937","DOI":"10.1016\/j.ejphar.2020.172937","volume":"871","author":"J\u00f3\u017awiak M.","year":"2020","unstructured":"J\u00f3\u017awiak M.; Filipowska A.; Fiorino F.; Struga M.; Anticancer activities of fatty acids and their heterocyclic derivatives. Eur J Pharmacol 2020,871,172937","journal-title":"Eur J Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2100629","DOI":"10.1002\/adma.202100629","volume":"33","author":"Liang T.","year":"2021","unstructured":"Liang T.; Wen D.; Chen G.; Chan A.; Chen Z.; Li H.; Wang Z.; Han X.; Jiang L.; Zhu J.J.; Gu Z.; Adipocyte\u2010derived anticancer lipid droplets. Adv Mater 2021,33(26),2100629","journal-title":"Adv Mater"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.matt.2019.08.007","volume":"1","author":"Wen D.","year":"2019","unstructured":"Wen D.; Wang J.; Adipocytes as anticancer. Matter 2019,1(5),1203-1214","journal-title":"Matter"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568009623666230201092302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213321\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568009623666230201092302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T15:25:52Z","timestamp":1691421952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213321\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009623666230201092302","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}